H. L. de Matos Guedes

This study shows that Leishmania amazonensis infection increases PD-L1 on dendritic cells via mTOR, leading to impaired Th1 responses and promoting lesion resolution.

This study evaluates a vaccine strategy using Alum and Poly(I:C) adjuvants with SARS-CoV-2 spike protein, showing enhanced antibody and T-cell responses and reduced lung inflammation.

This study investigates the therapeutic effects of anti-PD-1 and anti-PD-L1 antibodies in Leishmania amazonensis-infected mice, showing increased IFN-γ production and reduced parasite load.

This study shows that the yellow fever vaccine (17DD) protects both resistant and susceptible mice against Zika virus infection, reducing mortality, viral load, and neurological impairment.